Why is Akums Drugs falling/rising?

As of 24-Sep, Akums Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 465.00, which reflects a decrease of 5.6 points or 1.19%. The stock has underperformed its sector today by 0.74% and has been on a downward trend for the last three days, accumulating a total loss of 2.43%. Over the past week, the stock has decreased by 1.54%, and its performance over the last month shows a significant drop of 3.46%. Notably, the stock has generated a staggering return of -44.77% over the past year, while its profits have risen dramatically by 1362%. Despite a low debt-to-equity ratio and an attractive valuation with a price-to-book value of 2.4, the company faces challenges with poor long-term growth, as evidenced by its net sales growth of only 6.10% annually over the last five years.
In the broader market context, the stock's recent performance contrasts with the Sensex, which has shown a slight increase of 0.50% over the past month. The stock's liquidity appears adequate for trading, but the delivery volume has decreased by 3.72% compared to the five-day average, indicating falling investor participation. Furthermore, the company has reported below-par performance in both the near and long term, with a significant drop in PAT for the last quarter and the lowest operating profit to interest ratio recorded. This combination of factors contributes to the stock's ongoing decline, as it has consistently underperformed against the BSE500 over various time frames.